Similarly, the median number of mutations in TCGA BRCA1- and BRCA2-deficient breast cancers being 2.2 and 2.0 fold higher, respectively, compared to BRCA-proficient breast cancers (P = 6.6 x 10−9 and 6.0 x 10−6, respectively; Fig 1D). The gene discussed is BRCA2; the disease is breast carcinoma.